Search results
Vertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoVertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript May 9, 2024 Vertex Energy, Inc....
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...
Simply Wall St. via Yahoo Finance· 1 day agoAs you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest...
Vertex Energy First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 11 hours agoVertex Energy (NASDAQ:VTNR) First Quarter 2024 Results Key Financial Results Revenue: US$695.3m...
Vertex Energy Inc (VTNR) Q1 2024 Earnings Overview: Mixed Result
Guru Focus· 3 hours agoRevenue: Reported at $695.33 million, slightly above the estimated $690.82 million.Net Loss: Recorded a net loss of $17.7 million, below the estimated loss of
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo Finance· 3 days agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
Vertex First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoVertex (NASDAQ:VERX) First Quarter 2024 Results Key Financial Results Revenue: US$156.8m (up 18%...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Ami
Guru Focus· 6 hours agoThis announcement comes in the wake of a significant development where Vertex Pharmaceuticals Incorporated agreed to acquire Alpine for $65 per share in cash, a deal set to ...
Vertex Resource Group Ltd.'s (CVE:VTX) CEO Compensation Looks Acceptable To Us And Here's Why
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Vertex Resource Group to hold its Annual General Meeting on 15th of May Total pay for...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 3 days agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...